SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of ...

Gossamer Bio ( (GOSS)) has released its Q3 earnings. Here is a breakdown of the information Gossamer Bio presented to its investors. Gossamer Bio, Inc. is a clinical-stage biopharmaceutical ...

After several years of indefinite hiatus and on-and-off posting, Chris Onstad's massive web comic “Achewood” has started up again. Beginning in 2001, Achewood originally focused on a small cast of the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...